PubMed:32364677 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"SP_7"},{"id":"T2","span":{"begin":22,"end":28},"obj":"UBERON:0002113"},{"id":"T3","span":{"begin":113,"end":124},"obj":"UBERON:0001004"},{"id":"T4","span":{"begin":136,"end":142},"obj":"NCBITaxon:9606"},{"id":"T5","span":{"begin":165,"end":176},"obj":"NCBITaxon:11118"},{"id":"T6","span":{"begin":177,"end":187},"obj":"SP_7"},{"id":"T7","span":{"begin":218,"end":229},"obj":"NCBITaxon:11118"},{"id":"T8","span":{"begin":243,"end":251},"obj":"SP_7"},{"id":"T9","span":{"begin":383,"end":388},"obj":"UBERON:0002107"},{"id":"T10","span":{"begin":393,"end":399},"obj":"UBERON:0002113"},{"id":"T11","span":{"begin":424,"end":434},"obj":"SP_7"},{"id":"T12","span":{"begin":453,"end":464},"obj":"UBERON:0001004"},{"id":"T13","span":{"begin":598,"end":603},"obj":"CHEBI:67079"},{"id":"T14","span":{"begin":598,"end":603},"obj":"CHEBI:67079"},{"id":"T15","span":{"begin":603,"end":614},"obj":"NCBITaxon:11118"},{"id":"T16","span":{"begin":615,"end":620},"obj":"CHEBI:23888"},{"id":"T17","span":{"begin":615,"end":620},"obj":"CHEBI:23888"},{"id":"T18","span":{"begin":625,"end":632},"obj":"CHEBI:24505"},{"id":"T19","span":{"begin":625,"end":632},"obj":"CHEBI:24505"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"COVID-19 pneumonia in kidney transplant recipients- where we are?\nIn late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first COronaVIrusDisease 2019 (COVID-19) in Brazil was diagnosed and by now we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases."}

{"project":"hydroxychloroquine","denotations":[{"id":"T1","span":{"begin":9,"end":18},"obj":"Phenotype"},{"id":"T2","span":{"begin":113,"end":132},"obj":"Phenotype"},{"id":"T3","span":{"begin":435,"end":444},"obj":"Phenotype"},{"id":"T4","span":{"begin":453,"end":472},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002086"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002878"}],"text":"COVID-19 pneumonia in kidney transplant recipients- where we are?\nIn late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first COronaVIrusDisease 2019 (COVID-19) in Brazil was diagnosed and by now we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases."}